Author
Listed:
- Therese Vu
(QIMR Berghofer Medical Research Institute
University of Queensland
University of Colorado Anschutz Medical Campus)
- Jasmin Straube
(QIMR Berghofer Medical Research Institute)
- Amy H. Porter
(QIMR Berghofer Medical Research Institute)
- Megan Bywater
(QIMR Berghofer Medical Research Institute
University of Queensland)
- Axia Song
(QIMR Berghofer Medical Research Institute)
- Victoria Ling
(QIMR Berghofer Medical Research Institute
University of Queensland
Royal Brisbane and Women’s Hospital)
- Leanne Cooper
(QIMR Berghofer Medical Research Institute)
- Gabor Pali
(QIMR Berghofer Medical Research Institute)
- Claudia Bruedigam
(QIMR Berghofer Medical Research Institute)
- Sebastien Jacquelin
(QIMR Berghofer Medical Research Institute)
- Joanne Green
(QIMR Berghofer Medical Research Institute)
- Graham Magor
(Monash University)
- Andrew Perkins
(Monash University)
- Alistair M. Chalk
(St. Vincent’s Institute
University of Melbourne)
- Carl R. Walkley
(St. Vincent’s Institute
University of Melbourne
Australian Catholic University)
- Florian H. Heidel
(Universitätsklinikum Jena)
- Pamela Mukhopadhyay
(QIMR Berghofer Medical Research Institute)
- Nicole Cloonan
(QIMR Berghofer Medical Research Institute
University of Auckland)
- Stefan Gröschel
(German Cancer Research Center
Heidelberg University Hospital)
- Jan-Philipp Mallm
(German Cancer Research Center)
- Stefan Fröhling
(German Cancer Research Center
National Center for Tumor Diseases Heidelberg)
- Claudia Scholl
(German Cancer Research Center
National Center for Tumor Diseases Heidelberg)
- Steven W. Lane
(QIMR Berghofer Medical Research Institute
University of Queensland
Royal Brisbane and Women’s Hospital)
Abstract
The caudal-related homeobox transcription factor CDX2 is expressed in leukemic cells but not during normal blood formation. Retroviral overexpression of Cdx2 induces AML in mice, however the developmental stage at which CDX2 exerts its effect is unknown. We developed a conditionally inducible Cdx2 mouse model to determine the effects of in vivo, inducible Cdx2 expression in hematopoietic stem and progenitor cells (HSPCs). Cdx2-transgenic mice develop myelodysplastic syndrome with progression to acute leukemia associated with acquisition of additional driver mutations. Cdx2-expressing HSPCs demonstrate enrichment of hematopoietic-specific enhancers associated with pro-differentiation transcription factors. Furthermore, treatment of Cdx2 AML with azacitidine decreases leukemic burden. Extended scheduling of low-dose azacitidine shows greater efficacy in comparison to intermittent higher-dose azacitidine, linked to more specific epigenetic modulation. Conditional Cdx2 expression in HSPCs is an inducible model of de novo leukemic transformation and can be used to optimize treatment in high-risk AML.
Suggested Citation
Therese Vu & Jasmin Straube & Amy H. Porter & Megan Bywater & Axia Song & Victoria Ling & Leanne Cooper & Gabor Pali & Claudia Bruedigam & Sebastien Jacquelin & Joanne Green & Graham Magor & Andrew Pe, 2020.
"Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia,"
Nature Communications, Nature, vol. 11(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16840-2
DOI: 10.1038/s41467-020-16840-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16840-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.